| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +500 | 85.6% | $2.50 | +$1.25K |
| Sells | 2 | -84 | 14.4% | $2.17 | -$183 |
| Net | -1 | +416 | 71.2% | +$1.07K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. | 10%+ Owner | $497K | Apr 16, 2024 | ||
| Robert Davidow | 10%+ Owner | $171K | Dec 11, 2023 | ||
| Lucy Lu | President, CEO, Director | $105K | Dec 17, 2021 | ||
| Alexandra MacLean | Chief Executive Officer, Director | $23.8K | Sep 23, 2024 | ||
| Joseph Vazzano | Chief Financial Officer | $23.2K | Dec 17, 2021 | ||
| David Jin | Interim PFO and COO | $9.1K | Sep 23, 2024 | ||
| Jay D. Kranzler | Director | $1.25K | +$1.11K | +801% | Nov 5, 2024 |
| Neil Herskowitz | Director | $194 | -$46 | -19.2% | Dec 2, 2024 |
| InvaGen Pharmaceuticals, Inc. | 10%+ Owner | Oct 11, 2022 | |||
| Lindsay A. Md Rosenwald | Director | Sep 23, 2024 | |||
| Faith L. Charles | Director | Sep 23, 2024 | |||
| Curtis Gale Oltmans | Director | Sep 23, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|